LIPI — Lipidor AB Share News
0.000.00%
Last trade - 00:00- SEK174.88m
- SEK152.13m
- SEK0.01m
Brief: Lipidor Secures Bridge Financing Of About SEK 5 Mln, Introduces Cost Savings
Brief: Lipidor Q3 Operating Loss At SEK 12.2 Mln
Brief: Lipidor Says Still Sees Potential in AKP02
Brief: Lipidor Clinical Phase III Study Misses Primary Goal
Brief: Lipidor Updates On Phase III Clinical Study
Brief: Lipidor Appoints New CFO Charlotta Ekman
Brief: Lipidor Q2 EBIT Loss At SEK 8.8 Million
Brief: Lipidor Q1 Oper Loss Narrows To SEK 11.1 Mln
Brief: Lipidor Unit Emollivet Raises Capital
Brief: Lipidor Q4 Operating Loss Widens To SEK 12.0 Mln
Brief: Lipidor Invests In New Drug Development Project Against Acne Vulgaris
Brief: Lipidor Q3 Operating Income Turns To Profit Of SEK 3.4 Mln
Brief: Lipidor To Start Phase III Clinical Study Of AKP02
Brief: Lipidor Q2 Net Sales At SEK 2,000
Brief: Karolinska Development Sells Its Holding In Lipidor
Brief: Lipidor AB Licence Agreement Grants Menarini Group, Relife Srl,Exclusive Rights To Register, Promote, Distribute,Market 2New Psoriasis Drug Candidates
Brief: Lipidor Q1 Operating Loss Widens To SEK 4.4 Million
Brief: Lipidor: Unit Emollivet Receives Funding From Vinnova
Brief: Lipidor Updates On Phase III Clinical Trial Of Drug Candidate AKP02 For Treatment Of Psoriasis